Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Salicylic acid-functionalized iron oxide nanoparticles** are an experimental nanoparticle-based therapeutic composed of iron oxide nanoparticles surface-functionalized with salicylic acid. In the provided preclinical rat osteoarthritis study, orally administered SaIONPs were investigated as a targeted nanomedicine for knee osteoarthritis and were reported to localize to affected sites, reduce histologic cartilage damage, and lower biochemical markers of oxidative stress and inflammation including malondialdehyde and tumor necrosis factor alpha. The putative therapeutic rationale is a combination of nanoparticle-mediated tissue delivery with anti-inflammatory and antioxidant effects associated with the salicylic acid functionalization, but no validated single molecular target or commercial developer is clearly established from the provided source.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on salicylic acid-functionalized iron oxide nanoparticles.